| Name | bosutinib |
|---|---|
| Synonyms |
Bosutinib-13CD3
Bosutinib //BP Bosutinib(TINIBS ) Bosutinib/380-4 Bosulif) Bosulif(bosutinib) T66 BNJ DCN EMR BG DG EO1& HO1 IO3- AT6N DNTJ D1 SKI 606 - Bosutinib BOSUTINIB (SKI-606);SKI-606 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecbonitrile 3-Quinolinecbonitrile, 4-[(2,4-dichloro-5-Methoxyphenyl)amino]-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy] 4-(2,4-Dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile Bosutinib, 10 mM in DMSO BOSUTINIB Bosutinib ( SKI-606 ) 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile SKI-606 WAY-173606 Bosutinib CRS 380-4 Bosutinib Bosutinib(SKI 606) Bosutinib for Bosutinib control 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecbonitrile Bosutinib (SKI-606) Bosutinib Bosutinib for research SKI 606 Bosutinib, (HPLC) Bsutinib Bosutinib formate salt |
| Description | Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 649.7±55.0 °C at 760 mmHg |
| Melting Point | 116-120ºC |
| Molecular Formula | C26H29Cl2N5O3 |
| Molecular Weight | 530.446 |
| Flash Point | 346.7±31.5 °C |
| Exact Mass | 529.164734 |
| PSA | 82.88000 |
| LogP | 5.48 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.652 |
| Storage condition | room temp |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319-H413 |
| Precautionary Statements | P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Phrases | 36 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| Precursor 10 | |
|---|---|
| DownStream 2 | |